Update on Anti-Obesity Medications
Detailed, Practical Advice for Creating Patient-Specific Obesity Treatment Plans
Suitable for Endocrinologists, Obesity Medicine Specialists, Primary Care/Internists, Psychiatrists, Nurses/Nurse Practitioners, Physician Assistants
Update on Anti-Obesity Medications for Creating Effective Treatment Plans
Suitable for Endocrinologists, Obesity Medicine Specialists, Primary Care/Internists, Psychiatrists, Nurses/Nurse Practitioners, Physician Assistants
COURSE LECTURES
- Practical Solutions for Medication Access
- Unlocking the Potential of AOMs
- When Medications Miss the Mark
- Wrapping Up Obesity Treatment
COURSE FEATURES
- All lectures available now
- 4 AMA PRA Category 1 CME Credits™ included
- Course syllabus pdf with all slide content
- 12-month access to course recordings
100% Money Back Guarantee – See Terms & Conditions
Update on Anti-Obesity Medications Course
with Laura Davisson, MD, MPH, FACP
Obesity – Is it a Disease? You’ll Learn …
- The four pillars shaping modern obesity medicine
- Hidden criteria that guide anti-obesity prescribing
- The full spectrum of treatment most clinician’s underuse
Optimizing Chronic Medications – You’ll Learn …
- The common prescriptions quietly driving weight gain
- Diabetes drugs that double as weight management tools
- Deprescribing principles that reverse medication-linked weight gain
Anti-Obesity Medications I: Common Oral Agents – You’ll Learn …
- Patient selection rules that make AOMs succeed
- How to prescribe with confidence
- Off-label uses and the rules around duration
Anti-Obesity Medications II: GLP-1 Agonists – You’ll Learn …
- Troubleshooting tips when GLP-1s don’t go as planned
- New pipeline medications every obesity clinician should watch
- Practical prescribing insights you won’t find in textbooks
Anti-Obesity Medications III: Other Agents – You’ll Learn …
- The rare obesity disorders with FDA-approved therapies
- Medications that don’t deliver safe weight loss
- The long-term FDA-approved drugs that actually work
Individualizing Obesity Pharmacotherapy – You’ll Learn …
- How to tailor treatment for complex comorbidities
- Overcoming access barriers and advocating for patients
- Building personalized plans that win insurance approval
FEATURED EDITOR
Laura Davisson, MD
 | Board Certified Professor of Internal Medicine Founder and Director, Medical Weight Management Program |
Laura Davisson, MD, MPH, FACP is a board-certified internist and obesity medicine specialist with expertise in women’s health, prevention, and the treatment of obesity and metabolic disease. Her clinical and academic work focuses on addressing obesity as a root cause of many chronic conditions through evidence-based, patient-centered medical weight management. She founded and directs WVU Medicine’s Medical Weight Management program, working collaboratively with bariatric surgery to deliver comprehensive care. Dr. Davisson is deeply committed to medical education and workforce development in obesity medicine. She leads resident quality improvement and research initiatives, directs nutrition education, and established West Virginia’s first fellowship dedicated to training physicians in nutrition and metabolic diseases. An active national leader, she has served in multiple roles within the American College of Physicians and obesity-focused professional organizations, contributed to national clinical guidelines, and is a frequent speaker and advocate for the prevention and treatment of obesity and related illnesses. | |
CME ACCREDITATION
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.
Designation Statement:
Online Course, Release Date March 1, 2025, Termination Date February 29, 2028:
PeerPoint Medical Education Institute designates the live and enduring formats for this educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
MOC Accreditation Statement:
Successful completion of this CME activity enables the participant to earn up to 4 MOC points in the American Board of Internal Medicine’s (ABIM®) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM® MOC points.
Nurses & Nurse Practitioners: For all your CE requirements for recertification, the ANCC will accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Physician Assistants: The NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Licensed Psychologists: Most state boards will accept AMA PRA Category 1 Credits™ toward professional development hours. Please confirm with your state board before using this product for professional development hours.
Learn to Support and Empower Your Patients with Appropriate Weight Loss Treatment
Which medications are right for each of your patients? This course will help you know.
The best obesity treatment for a particular patient will depend on their individual needs and circumstances. Some factors to consider include the patient’s age, weight, health history, and other medications they are taking.Common weight loss medications covered in this course:
By staying informed about the latest advancements in weight management medications, you can help your patients achieve their weight loss goals and improve their overall health. Some of the most common anti-obesity medications for weight loss treatment covered in this course include:- Semaglutide (Wegovy): This medication is a newer once weekly injectable medication that works by mimicking a gut hormone that helps regulate appetite.
- Liraglutide (Saxenda): This medication is a daily injectable medication that works by mimicking a gut hormone that helps regulate appetite.
- Orlistat (Xenical, Alli): This medication works by blocking fat absorption from food.
- Phentermine (Adipex-P): This medication is a stimulant that suppresses appetite.
- Topiramate/phentermine (Qsymina): This medication combines two medications to suppress appetite.
- Naltrexone/bupropion (Contrave): This medication combines two medications that work together to reduce hunger and increase energy expenditure.
- Up-and-coming medications in the pipeline and off label use of medications to promote weight loss
American Physician
